Jun-Pyo Myong Republic of Korea

Clinician-scientist with over 20 years of expertise in Occupational and Environmental Medicine, specializing in work-related respiratory diseases including pneumoconiosis (silicosis, coal workers' pneumoconiosis, asbestosis) and humidifier disinfectant-induced lung disease. Experienced in epidemiology, field surveys, pulmonary function testing (PFT), and AI-based medical approaches. Active contributor to national and international health policy and surveillance programs, including WHO Collaborating Centre activities and the Asian Pacific Society of Respirology (APSR).
Job Title
Professor
Faculty / Department / Division
Department of Occupational and Environmental Medicine
Institution / Organisation
The Catholic University of Korea, Seoul St. Mary's Hospital

20 November 2026, Friday

Time Session
09:30
11:00
11:00
12:00
Irfhan Ali Hyder Ali Chairperson Malaysia
Jun-Pyo Myong Chairperson Republic of Korea
  • Metin Akgün Speaker Turkiye
  • Jun-Pyo Myong Speaker Republic of Korea
    Background: Pneumoconiosis may progress as progressive pulmonary fibrosis (PPF), yet evidence for nintedanib in this population is limited. We describe six treated patients and barriers to access under Korea's workers' compensation system. Methods: We retrospectively reviewed six patients with pneumoconiosis or asbestosis who initiated nintedanib at a tertiary hospital between January 2025 and June 2026. Serial forced vital capacity (FVC), high-resolution computed tomography (HRCT), respiratory symptoms, and serum KL-6 were assessed. Results: All patients were men aged 64–88 years; five had dust-related pneumoconiosis and one had environmental asbestosis. Each showed at least two indicators of progression: FVC decline, radiological worsening, or worsening symptoms. Before treatment, five patients had relative FVC declines of 10.7–22.6%; one had gradual long-term decline with HRCT progression. After initiation, three reported symptomatic improvement. Of four patients with follow-up spirometry, two had relatively stable FVC and two had further declines. KL-6 decreased in two patients (1,191 to 869 U/mL; 546 to 451 U/mL). Post-treatment spirometry was unavailable for two patients. Two aftercare patients required case-by-case review for reimbursement. Conclusions: Nintedanib use was accompanied by symptomatic improvement or FVC stabilization in some patients with pneumoconiosis-associated PPF. Small sample size, limited follow-up, and lack of controls prevent causal inference. Reimbursement criteria for pneumoconiosis aftercare warrant revision to improve access to antifibrotic therapy.
  • Siti Munira Yasin Speaker Malaysia
    Occupational lung diseases are largely preventable, yet many cases in Malaysia remain undetected and under-reported. One of the main challenges is recognising the link between workplace exposures and respiratory symptoms, particularly when diseases develop gradually over many years. This presentation discusses the current burden of occupational lung diseases in Malaysia, common workplace exposures, approaches to diagnosis, preventive measures and relevant occupational health legislation. Findings from the National Occupational Disease Prevention Programme (NODiP), which screened 116,939 workers across seven critical industries, provide insights into the burden of suspected occupational respiratory diseases beyond routine notification data. The presentation also highlights how digital screening, workplace hazard assessment and emerging technologies, including artificial intelligence, could improve early detection and surveillance. Moving forward, closer collaboration between respiratory physicians, occupational health practitioners, employers and regulatory authorities is needed to identify high-risk workers, strengthen workplace interventions and prevent occupational lung diseases before irreversible damage occurs.
  • Q&A
Ballroom 2, Lower Ground Floor

22 November 2026, Sunday

Time Session
11:00
12:00
Chinatsu Nishida Chairperson Japan
Nurhayati Mohd Marzuki Chairperson Malaysia
  • Jun-Pyo Myong Speaker Republic of Korea
    "Floods are the most frequent natural disaster worldwide, yet their respiratory health consequences remain comparatively under-recognised. Unlike drowning and traumatic injury, many respiratory effects emerge after floodwaters recede and arise through multiple, interacting pathways. This presentation conceptualises flooding as a sequence of respiratory exposures involving contaminated floodwater, displacement and shelter crowding, water-damaged housing, restoration and cleanup work, and disruption of ongoing healthcare. Growing epidemiological evidence indicates that the respiratory burden may extend well beyond the emergency phase. In a recent study of more than 300 million hospitalisations across 747 communities in eight countries and territories, flood exposure was associated with a cumulative relative risk of 1.30 (95% CI 1.13–1.49) for respiratory hospitalisation, with a delayed, inverted U-shaped lag-response and increased risk persisting for up to 210 days. Following the 2011 Great East Japan earthquake and tsunami, pneumonia hospitalisations increased 5.7-fold, although only 3.6% of post-disaster pneumonia cases were associated with near-drowning. Shelter crowding further increased the incidence of acute respiratory infection. The recovery environment creates additional and potentially modifiable exposures. Flood-damaged housing is associated with persistent dampness and mould, while demolition and restoration work can generate substantial exposure to particulate matter, endotoxin, and fungal glucans. Flood-related infections also remain clinically relevant; historical Korean leptospirosis outbreaks following floods and heavy rainfall demonstrate the interaction between environmental exposure, agricultural work, and severe pulmonary manifestations. Importantly, effect estimates vary across settings, reflecting differences in flood characteristics, housing, population vulnerability, exposure assessment, healthcare access, and recovery conditions. Comparative evidence regarding the effectiveness of post-flood respiratory interventions remains limited. For the Asia-Pacific region, priorities include standardised flood-exposure assessment, longitudinal respiratory surveillance, evaluation of housing and bioaerosol exposures, protection of cleanup workers, continuity of chronic respiratory and tuberculosis care, and rigorous evaluation of preventive interventions. Respiratory health should therefore be incorporated into flood preparedness and recovery well beyond the immediate disaster response. Keywords: flooding; respiratory health; dampness and mould; occupational exposure; disaster preparedness; Asia-Pacific"
  • Kang Mo Gu Speaker Republic of Korea
    Title: Wildfire and Respiratory Health Abstract Wildfires are becoming larger, longer and more frequent, and the Asia-Pacific region is among the areas where wildfire-derived PM2.5 is rising fastest. Landscape-fire air pollution already accounts for an estimated 1.5 million deaths a year, 220,000 of them respiratory, and is projected to grow with each increment of warming. This lecture summarises what wildfire smoke does to the respiratory system and what clinicians can do about it. Wildfire PM2.5 is not urban PM2.5. It is finer, more oxidative and more pro-inflammatory, and it arrives as short, extreme peaks rather than a steady background. Gram for gram, it carries greater macrophage toxicity than urban particulate matter, and oxidative stress is the common pathway of airway injury. Epidemiological evidence is consistent in direction across more than 30 studies of asthma and COPD, although effect sizes vary with how exposure is defined and how vulnerable the population is. Per microgram, smoke PM2.5 increases asthma emergency visits several-fold more than non-smoke PM2.5, and recent large cohorts show the same pattern for long-term exposure, including a 4.6-fold higher per-microgram mortality hazard among older patients with lung cancer. Korean data from the 2017 Samcheok and 2023 Gangneung fires show that respiratory healthcare use rises during the fire, remains elevated for weeks after containment, and is highest in young children — even after an 8-hour fire. The lecture closes with practical responses: identifying high-risk patients, preparing smoke action plans before the season, protecting patients during and after the episode, and strengthening health-system preparedness as wildfire seasons lengthen.
  • Duminda Yasaratne Speaker Sri Lanka
    Climate change is rapidly emerging as one of the defining threats to respiratory health in the 21st century. Rising temperatures, heatwaves, changing aeroallergen patterns and increasing air pollution are altering the epidemiology and severity of respiratory diseases worldwide. These impacts are particularly important for vulnerable populations with asthma, COPD, respiratory infections and chronic lung diseases. The Asia-Pacific region is at the forefront of this challenge. Rapid urbanisation, population density, biomass and fossil-fuel dependence, transboundary air pollution, extreme weather events and climate-sensitive infectious diseases create a complex and interconnected respiratory health burden, influencing both acute respiratory events and long-term lung health. This lecture will explore the global evidence linking climate change with respiratory disease, while highlighting emerging threats and opportunities across the Asia-Pacific region. It will examine the intersection of climate change, air pollution and health inequities, and consider the implications for clinical practice, respiratory services and public health. The session will emphasize the pivotal role of respiratory specialists in climate advocacy, adaptation, prevention and mitigation, and building climate-resilient respiratory health systems.
  • Q&A
Ballroom 2, Lower Ground Floor